Published in J Chromatogr on May 20, 1992
Population pharmacokinetics of stavudine (d4T) in patients with AIDS or advanced AIDS-related complex. Antimicrob Agents Chemother (1995) 1.08
Determination of dosing guidelines for stavudine (2',3'-didehydro-3'-deoxythymidine) in children with human immunodeficiency virus infection. Antimicrob Agents Chemother (2001) 0.99
Pharmacokinetics of the anti-human immunodeficiency virus nucleoside analog stavudine in cynomolgus monkeys. Antimicrob Agents Chemother (1993) 0.94
Pharmacokinetics and safety of a single dose of stavudine (d4T) in patients with severe hepatic impairment. Antimicrob Agents Chemother (1997) 0.88
Radioimmunoassay for quantitation of 2',3'-didehydro-3'-deoxythymidine (D4T) in human plasma. Antimicrob Agents Chemother (1996) 0.80
Pharmacokinetics of single-dose oral stavudine in subjects with renal impairment and in subjects requiring hemodialysis. Antimicrob Agents Chemother (2000) 0.76
Sequence and analysis of chromosome 2 of the plant Arabidopsis thaliana. Nature (1999) 8.04
Evaluation of chest pain in the emergency department. Ann Intern Med (1994) 7.12
Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation (1998) 5.93
Genetic definition and sequence analysis of Arabidopsis centromeres. Science (1999) 4.20
Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation (2001) 3.15
Assessment of right ventricular function using two-dimensional echocardiography. Am Heart J (1984) 3.09
An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N Engl J Med (1992) 2.81
Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. J Natl Cancer Inst (1996) 2.51
Disinfection methods in general practice and health authority clinics: a telephone survey. J R Coll Gen Pract (1988) 2.41
Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue. Circulation (1998) 2.37
ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association. J Am Coll Cardiol (1999) 2.37
Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound. Circulation (1998) 2.30
Sequence and analysis of chromosome 3 of the plant Arabidopsis thaliana. Nature (2000) 2.17
American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on cardiac catheterization laboratory standards. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol (2001) 2.09
Noninvasive ultrasound imaging of inflammation using microbubbles targeted to activated leukocytes. Circulation (2000) 2.07
High-pressure liquid chromatographic analysis of BMY-28142 in plasma and urine. Antimicrob Agents Chemother (1987) 1.94
Pharmacokinetics of stavudine in patients with AIDS or AIDS-related complex. J Infect Dis (1992) 1.94
Use of sildenafil (Viagra) in patients with cardiovascular disease. Technology and Practice Executive Committee. Circulation (1999) 1.87
Sequence and analysis of chromosome 1 of the plant Arabidopsis thaliana. Nature (2000) 1.85
Physiologic hyperinsulinemia enhances human skeletal muscle perfusion by capillary recruitment. Diabetes (2001) 1.80
Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction. New insights using myocardial contrast echocardiography. Circulation (1994) 1.79
Quantification of renal blood flow with contrast-enhanced ultrasound. J Am Coll Cardiol (2001) 1.77
Contrast echocardiography: current and future applications. J Am Soc Echocardiogr (2000) 1.76
Inter- and intrapatient variability in etoposide kinetics with oral and intravenous drug administration. Clin Cancer Res (1999) 1.70
American College of Cardiology/American Heart Association Expert Consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. Circulation (2000) 1.69
Post-ischaemic myocardial dysfunction (stunning) results from myofibrillar oedema. Heart (2007) 1.67
Meningococcal disease in Wales: clinical features, outcome and public health management. J Infect (1992) 1.60
Sarcoglycanopathies: a clinico-pathological study. Neurol India (2007) 1.59
Pharmacokinetics of didanosine in patients with acquired immunodeficiency syndrome or acquired immunodeficiency syndrome-related complex. Clin Pharmacol Ther (1991) 1.58
Targeted ultrasound contrast agent for molecular imaging of inflammation in high-shear flow. Contrast Media Mol Imaging (2006) 1.58
Analysis of potential risk factors associated with the development of pancreatitis in phase I patients with AIDS or AIDS-related complex receiving didanosine. J Infect Dis (1994) 1.55
Effect of salmeterol on respiratory muscle activity during exercise in poorly reversible COPD. Thorax (2004) 1.52
In vivo myocardial kinetics of air-filled albumin microbubbles during myocardial contrast echocardiography. Comparison with radiolabeled red blood cells. Circ Res (1994) 1.48
Association of tumor necrosis factor-α and matrix metalloproteinase-3 gene variants with stroke. Eur J Neurol (2011) 1.47
Complex mtDNA constitutes an approximate 620-kb insertion on Arabidopsis thaliana chromosome 2: implication of potential sequencing errors caused by large-unit repeats. Proc Natl Acad Sci U S A (2001) 1.47
Efficient utilization of echocardiography for the assessment of left ventricular systolic function. Am Heart J (2000) 1.46
Relationship between left ventricular wall thickness and left atrial size: comparison with other measures of diastolic function. J Am Soc Echocardiogr (1995) 1.46
Prevalence and pattern of major neurological disorders in rural Kashmir (India) in 1986. Neuroepidemiology (1994) 1.45
Noninvasive quantification of coronary blood flow reserve in humans using myocardial contrast echocardiography. Circulation (2001) 1.44
Noninvasive imaging of inflammation by ultrasound detection of phagocytosed microbubbles. Circulation (2000) 1.43
Quantitation of didanosine in human plasma and urine by high-performance liquid chromatography. J Chromatogr (1990) 1.42
Microbubble persistence in the microcirculation during ischemia/reperfusion and inflammation is caused by integrin- and complement-mediated adherence to activated leukocytes. Circulation (2000) 1.39
Hollow-fiber unit evaluation of a new human immunodeficiency virus type 1 protease inhibitor, BMS-232632, for determination of the linked pharmacodynamic variable. J Infect Dis (2001) 1.38
A phase I/II evaluation of stavudine (d4T) in children with human immunodeficiency virus infection. Pediatrics (1995) 1.37
Effects of recombinant apolipoprotein A-I(Milano) on aortic atherosclerosis in apolipoprotein E-deficient mice. Circulation (1998) 1.34
Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis. J Clin Oncol (1992) 1.32
Interactions between microbubbles and ultrasound: in vitro and in vivo observations. J Am Coll Cardiol (1997) 1.31
Postoperative pain after cholecystectomy: Conventional laparoscopy versus single-incision laparoscopic surgery. J Minim Access Surg (2011) 1.30
Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: evidence for activation by proinflammatory mediators. Circulation (1999) 1.28
Functional significance of collateral blood flow in patients with recent acute myocardial infarction. A study using myocardial contrast echocardiography. Circulation (1992) 1.27
The behavior of sonicated albumin microbubbles within the microcirculation: a basis for their use during myocardial contrast echocardiography. Circ Res (1989) 1.25
Role of capillaries in determining CBF reserve: new insights using myocardial contrast echocardiography. Am J Physiol (1999) 1.24
In vitro and in vivo disposition and metabolism of 3'-deoxy-2',3'-didehydrothymidine. Antimicrob Agents Chemother (1993) 1.23
Management of sexual dysfunction in patients with cardiovascular disease: recommendations of The Princeton Consensus Panel. Am J Cardiol (2000) 1.20
Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing is coming, part I. Circulation (2001) 1.19
Decreased neointimal thickening after arterial wall injury in inducible nitric oxide synthase knockout mice. Circ Res (2000) 1.19
Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure. J Am Coll Cardiol (1999) 1.19
Basis for detection of stenosis using venous administration of microbubbles during myocardial contrast echocardiography: bolus or continuous infusion? J Am Coll Cardiol (1998) 1.19
Acute transverse myelitis: MR characteristics. Neurol India (1999) 1.18
Brain metastasis model in athymic nude mice using a novel MUC1-secreting human breast-cancer cell line, MA11. Int J Cancer (1996) 1.15
Assessment of resting perfusion with myocardial contrast echocardiography: theoretical and practical considerations. Am Heart J (2000) 1.13
Tenascin-C is expressed in macrophage-rich human coronary atherosclerotic plaque. Circulation (1999) 1.12
Diagnostic value of echocardiography in suspected endocarditis. An evaluation based on the pretest probability of disease. Circulation (1996) 1.11
Noninvasive prediction of ultimate infarct size at the time of acute coronary occlusion based on the extent and magnitude of collateral-derived myocardial blood flow. Circulation (2001) 1.11
Primary fibrosarcoma of brain. Neurol India (2000) 1.10
Prediction of outcome after mitral valve replacement in patients with symptomatic chronic mitral regurgitation. The importance of left atrial size. Circulation (1991) 1.10
Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages. Circulation (1999) 1.09
Identification of the Escherichia coli lytB gene, which is involved in penicillin tolerance and control of the stringent response. J Bacteriol (1993) 1.08
Population pharmacokinetics of stavudine (d4T) in patients with AIDS or advanced AIDS-related complex. Antimicrob Agents Chemother (1995) 1.08
Value of regional wall motion abnormality in the emergency room diagnosis of acute myocardial infarction. A prospective study using two-dimensional echocardiography. Circulation (1991) 1.07
Changes in myocardial blood volume with graded coronary stenosis. Am J Physiol (1997) 1.05
Perivascular delivery of a nitric oxide donor inhibits neointimal hyperplasia in vein grafts implanted in the arterial circulation. J Thorac Cardiovasc Surg (1998) 1.05
Oral bioavailability and disposition characteristics of irbesartan, an angiotensin antagonist, in healthy volunteers. J Clin Pharmacol (1998) 1.05
Blood glucose and platelet-dependent thrombosis in patients with coronary artery disease. J Am Coll Cardiol (2000) 1.04
Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer. Int J Cancer (1998) 1.04
Quantification of cerebral perfusion with "Real-Time" contrast-enhanced ultrasound. Circulation (2001) 1.03
Effects of radiofrequency catheter ablation on regional myocardial blood flow. Possible mechanism for late electrophysiological outcome. Circulation (1994) 1.03
Characterization of spatial patterns of flow within the reperfused myocardium by myocardial contrast echocardiography. Implications in determining extent of myocardial salvage. Circulation (1993) 1.03
Coronary and myocardial blood volumes: noninvasive tools to assess the coronary microcirculation? Circulation (1997) 1.03
Non-invasive ventilation in chronic obstructive pulmonary disease: management of acute type 2 respiratory failure. Clin Med (2008) 1.02
Changes in myocardial blood volume over a wide range of coronary driving pressures: role of capillaries beyond the autoregulatory range. Heart (2004) 1.01
Recent advances in myocardial contrast echocardiography. Curr Opin Cardiol (1997) 1.01
Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection. J Am Coll Cardiol (1996) 1.00
Myocardial perfusion imaging in the setting of coronary artery stenosis and acute myocardial infarction using venous injection of a second-generation echocardiographic contrast agent. Circulation (1997) 1.00
Functional improvement precedes structural regression of atherosclerosis. Circulation (1994) 1.00
Dobutamine echocardiography for determining the extent of myocardial salvage after reperfusion. An experimental evaluation. Circulation (1994) 0.99
Simultaneous high-performance liquid chromatographic analysis of cefprozil diastereomers in a pharmacokinetic study. Pharm Res (1991) 0.99
Bladder preservation in adult classic exstrophy: early results of four patients. Urology (2001) 0.99
Expression of MUC-1 epitopes on normal bone marrow: implications for the detection of micrometastatic tumor cells. J Clin Oncol (1999) 0.98
Coronary angiography cannot be used to assess myocardial perfusion in patients undergoing reperfusion for acute myocardial infarction. Heart (2001) 0.98
The effect of interferon on the metabolism of LDLs. Arterioscler Thromb (1992) 0.98
Assessment of risk area during coronary occlusion and infarct size after reperfusion with myocardial contrast echocardiography using left and right atrial injections of contrast. Circulation (1993) 0.98
Effects of successful intravenous reperfusion therapy on regional myocardial function and geometry in humans: a tomographic assessment using two-dimensional echocardiography. J Am Coll Cardiol (1989) 0.98
Effect of revascularization on left ventricular remodeling in patients with heart failure from severe chronic ischemic left ventricular dysfunction. Am J Cardiol (2001) 0.97
Value and limitations of current methods of evaluating patients presenting to the emergency room with cardiac-related symptoms for determining long-term prognosis. Am J Cardiol (1992) 0.97
Quantification of myocardial perfusion with myocardial contrast echocardiography during left atrial injection of contrast. Implications for venous injection. Circulation (1994) 0.97
Oral magnesium supplementation inhibits platelet-dependent thrombosis in patients with coronary artery disease. Am J Cardiol (1999) 0.97
Low intracellular magnesium levels promote platelet-dependent thrombosis in patients with coronary artery disease. Am Heart J (2000) 0.97